BI
DMAA

Bulldog Investors’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Bulldog Investors’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-130,264
Closed -$1.35M – 239
2025
Q4 		$1.35M Hold
130,264
– – 0.3% 82
2025
Q3 		$1.34M Buy
130,264
+57,300
+79% +$588K 0.31% 79
2025
Q2 		$744K Buy
+72,964
New +$738K 0.19% 88

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.22% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bulldog Investors's DMAA Position: Q1 2026 in Review

Bulldog Investors sold out of Drugs Made In America Acquisition Corp (DMAA) in Q1 2026, closing a stake of 130,264 shares — an estimated $1.35M sold.

Bulldog Investors first reported a position in DMAA in Q2 2025 and held it in 3 quarters. The position peaked at $1.35M in Q4 2025. 39 funds tracked by Wall St. Rank hold DMAA as of Q1 2026.

  • Bulldog Investors reported no remaining Drugs Made In America Acquisition Corp position as of Q1 2026 after selling out during the quarter.
  • Bulldog Investors sold 130,264 Drugs Made In America Acquisition Corp shares in Q1 2026, an estimated $1.35M.
  • Bulldog Investors first reported a position in Drugs Made In America Acquisition Corp in Q2 2025 and held it in 3 quarters.
  • Bulldog Investors's Drugs Made In America Acquisition Corp position peaked at $1.35M in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q1 2026.

Based on Bulldog Investors's 13F filing for Q1 2026, filed 8 May 2026.